【Objective】 To investigate the prognosis of cervical adenocarcinoma by analyzing the clinical and follow-up data.【Methods】 Clinical and pathological data of 125 cases of cervical adenocarcinoma hospitalized in Department of Obstetrics and Gynecology of the First Affiliated Hospital of Sun Yat-san University from January 2000 to October 2010 were retrospectively analyzed. 【Results】 Median age of these cases was 45 years. According to FIGO staging system

the overall 5-year survival rate was 75.5%

and it was 93.4%

66.7%

and 30.0% for stages Ⅰ

Ⅱ

and Ⅲ

respectively. The FIGO stages

carcinoma diameter

and grading of tumor were independent factors of the survival rate for cervical adenocarcinoma patients. The prognosis of 39 cases at stages Ⅱ who received different treatments were not statistically significant (P = 0.122). In the 102 surgery cases

63 cases received bilateral accessories resection

4 cases suffered from ovarian metastasis

and one of those was of stage ⅡB

three of those were of stage Ⅲ. However

in the 39 surgery cases preserving ovarian function

2 cases suffered from ovarian metastasis in the work of follow-up. In this study

proportion of ovarian metastasis with pathological diagnosis was 5.9% (6/102). In the surgery patients

whether preserving ovarian function were not statistically significant (P > 0.05). 25 cases with apparently normal cervix uteri received liquid based cytology test and 80% of these cases presented pathological changes.【Conclusions】 Patients with late FIGO stages

carcinoma diameter over 4 cm and poorly differentiation had worse prognosis. Radical hysterectomy and comprehensive therapy involving radical hysterectomy were the main treatments of cervical adenocarcinoma

preserving ovarian function could be applied in young women with early stages. Liquid based cytology test was conducive to early diagnosis of cervical adenocarcinoma with nonspecific signs and symptoms.